相关实验视频

Updated: Jul 20, 2025

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

提高类疫苗在癌症免疫治疗中的疗效

Fatemeh Zahedipour¹, Khadijeh Jamialahmadi², Parvin Zamani³

¹Department of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.

International immunopharmacology

|August 5, 2023

概括

类疫苗在癌症免疫治疗方面表现有前途,但在持续免疫反应方面面临挑战. 通过个性化方法和组合疗法增强免疫性是改善临床结果的关键.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
疫苗学疫苗学疫苗学

背景情况:

类疫苗通过刺激对瘤抗原的免疫反应,为癌症免疫疗法提供了有针对性的方法.
在目前的类疫苗策略中,实现持久的免疫反应和显著的临床益处仍然存在挑战.

研究的目的:

审查癌症免疫治疗中类疫苗的当前情况.
探索增强类疫苗疗效和免疫原性的策略.

主要方法:

总结了临床前和临床类疫苗开发的进展.
讨论新的辅助剂,新抗原和纳米输送系统.
突出个性化疫苗方法和策略,如多价值和结合.

主要成果:

最近的发展包括新型辅助剂,新抗原,纳米输送系统和组合疗法.
根据个体患者个人资料量身定制的个性化癌症疫苗至关重要.
提高免疫性能的策略包括多价,结合,融合蛋白和自组合.

结论:

类疫苗,虽然仅仅是弱免疫原,但可以显著增强.
将类疫苗与其他免疫疗法结合起来,并开发个性化疫苗,有望提高疗效和临床结果.

关键词:

癌症免疫疗法癌症免疫疗法新抗原是一种新抗原.类疫苗类疫苗与瘤相关的抗原.疫苗治疗是用疫苗进行的.

更多相关视频

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

相关概念视频

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...